These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
463 related articles for article (PubMed ID: 33214960)
1. Can Neuron Specific Enolase Be a Diagnostic Biomarker for Neuronal Injury in COVID-19? Ganti L; Serrano E; Toklu HZ Cureus; 2020 Oct; 12(10):e11033. PubMed ID: 33214960 [TBL] [Abstract][Full Text] [Related]
2. Encephalopathy in COVID-19 Presenting With Acute Aphasia Mimicking Stroke. Pensato U; Muccioli L; Pasini E; Tappatà M; Ferri L; Volpi L; Licchetta L; Battaglia S; Rossini G; Bon I; Re MC; Cirillo L; Simonetti L; Gramegna LL; Michelucci R; Cortelli P; Zini A; Bisulli F Front Neurol; 2020; 11():587226. PubMed ID: 33193051 [No Abstract] [Full Text] [Related]
3. The usefulness of neuron-specific enolase in cerebrospinal fluid to predict neurological prognosis in cardiac arrest survivors who underwent target temperature management: A prospective observational study. You Y; Park JS; Min J; Yoo I; Ahn HJ; Cho Y; Ryu S; Lee J; Kim S; Cho S; Oh S; Jeong W; Kang C; Oh E; Lee IH; Lee B; Lee D; Youn CS Resuscitation; 2019 Dec; 145():185-191. PubMed ID: 31585184 [TBL] [Abstract][Full Text] [Related]
4. Neuron-Specific Enolase as a Biomarker: Biochemical and Clinical Aspects. Isgrò MA; Bottoni P; Scatena R Adv Exp Med Biol; 2015; 867():125-43. PubMed ID: 26530364 [TBL] [Abstract][Full Text] [Related]
6. Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children. Berger RP; Pierce MC; Wisniewski SR; Adelson PD; Clark RS; Ruppel RA; Kochanek PM Pediatrics; 2002 Feb; 109(2):E31. PubMed ID: 11826241 [TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid levels of neuron-specific enolase predict the severity of brain damage in newborns with neonatal hypoxic-ischemic encephalopathy treated with hypothermia. León-Lozano MZ; Arnaez J; Valls A; Arca G; Agut T; Alarcón A; Garcia-Alix A PLoS One; 2020; 15(6):e0234082. PubMed ID: 32479533 [TBL] [Abstract][Full Text] [Related]
8. Use of neuron-specific enolase for assessing the severity and outcome in patients with neurological disorders. Lima JE; Takayanagui OM; Garcia LV; Leite JP Braz J Med Biol Res; 2004 Jan; 37(1):19-26. PubMed ID: 14689039 [TBL] [Abstract][Full Text] [Related]
9. Elevated neuron-specific enolase and S100 calcium-binding protein B concentrations in cerebrospinal fluid of patients with anti-N-methyl-d-aspartate receptor encephalitis. Liu B; Xie Z; Liu G; Gu Y; Pan S; Wang H Clin Chim Acta; 2018 May; 480():79-83. PubMed ID: 29329729 [TBL] [Abstract][Full Text] [Related]
10. "Neurological manifestations of COVID-19" - guideline of the German society of neurology. Berlit P; Bösel J; Gahn G; Isenmann S; Meuth SG; Nolte CH; Pawlitzki M; Rosenow F; Schoser B; Thomalla G; Hummel T Neurol Res Pract; 2020; 2():51. PubMed ID: 33283160 [TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid in COVID-19 neurological complications: no cytokine storm or neuroinflammation. Garcia MA; Barreras PV; Lewis A; Pinilla G; Sokoll LJ; Kickler T; Mostafa H; Caturegli M; Moghekar A; Fitzgerald KC; Pardo CA medRxiv; 2021 Jan; ():. PubMed ID: 33469596 [TBL] [Abstract][Full Text] [Related]
12. Correlation of Brain Biomarker Neuron Specific Enolase (NSE) with Degree of Disability and Neurological Worsening in Cerebrovascular Stroke. Bharosay A; Bharosay VV; Varma M; Saxena K; Sodani A; Saxena R Indian J Clin Biochem; 2012 Apr; 27(2):186-90. PubMed ID: 23542317 [TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid findings and hypernatremia in COVID-19 patients with altered mental status. Toklu H; Ganti L; Crimi E; Cintron C; Hagan J; Serrano E Int J Emerg Med; 2020 Dec; 13(1):63. PubMed ID: 33297938 [TBL] [Abstract][Full Text] [Related]
14. Status epilepticus increases CSF levels of neuron-specific enolase and alters the blood-brain barrier. Correale J; Rabinowicz AL; Heck CN; Smith TD; Loskota WJ; DeGiorgio CM Neurology; 1998 May; 50(5):1388-91. PubMed ID: 9595992 [TBL] [Abstract][Full Text] [Related]
15. Neuron specific enolase: a promising therapeutic target in acute spinal cord injury. Haque A; Ray SK; Cox A; Banik NL Metab Brain Dis; 2016 Jun; 31(3):487-95. PubMed ID: 26847611 [TBL] [Abstract][Full Text] [Related]
16. Serum and CSF neuron-specific enolase in patients with West syndrome. Suzuki Y; Toribe Y; Goto M; Kato T; Futagi Y Neurology; 1999 Nov; 53(8):1761-4. PubMed ID: 10563625 [TBL] [Abstract][Full Text] [Related]
17. Detection of neuron specific enolase concentrations in cerebrospinal fluid from patients with neurological disorders by means of a sensitive enzyme immunoassay. Vermuyten K; Lowenthal A; Karcher D Clin Chim Acta; 1990 Feb; 187(2):69-78. PubMed ID: 2317937 [TBL] [Abstract][Full Text] [Related]
18. Serum and CSF levels of neuron-specific enolase (NSE) in cardiac surgery with cardiopulmonary bypass: a marker of brain injury? Schmitt B; Bauersfeld U; Schmid ER; Tuchschmid P; Molinari L; Fanconi S; Bandtlow C Brain Dev; 1998 Oct; 20(7):536-9. PubMed ID: 9840675 [TBL] [Abstract][Full Text] [Related]
19. Studies of neuron-specific enolase levels in serum and cerebrospinal fluid of children with neurological diseases. Ko FJ; Chiang CH; Wu CC; Wu L Gaoxiong Yi Xue Ke Xue Za Zhi; 1990 Mar; 6(3):137-43. PubMed ID: 2342156 [TBL] [Abstract][Full Text] [Related]
20. Normal CSF neuron-specific enolase and S-100 protein levels in patients with recent non-complicated tonic-clonic seizures. Palmio J; Peltola J; Vuorinen P; Laine S; Suhonen J; Keränen T J Neurol Sci; 2001 Jan; 183(1):27-31. PubMed ID: 11166790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]